Zurueck zur Suche

Reporte zur Charge UJ751AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 2 TX 1 WI 1

VAERS 1868489

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ751AA

mild
Staat
TX
Alter
95,0
Geschlecht
F
Eingang
14.11.2021
Impfdatum
12.11.2021
Beginn
13.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Injection site pain Injection site warmth

Symptomtext

PATIENT REPORT OF HEACHE, INJECTION SIDE TENDER AND WARM TO TOUCH. REACTION STARTED DAY AFTER INJECTION. HER TEMP WAS 97.0 WHEN SHE REPORTED IT AND I COULDNT SEE ANY VISIBLE SWOLLEN AT THE SITE. I INFORMED THE PATIENT TO REACH OUT TO HER DOCTOR OR SEEK MEDICAL ATTENTION FROM URGENT CARE. I ALSO INFORMED HER TO TAKE TYLENOL FOR THE PAIN AND USE ICE PACK AT THE SITE OF INJECTION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
NONE AT THE MOMENT
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
NKDA LISTED
Vorherige Impfungen
-

VAERS 1909644

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ751AA

gering
Staat
WI
Alter
88,0
Geschlecht
F
Eingang
30.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient received 2 flu vaccines in same year

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1824752

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ751AA

gering
Staat
NY
Alter
3,0
Geschlecht
F
Eingang
28.10.2021
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Adverse reaction Medication error Overdose Product administered to patient of inappropriate age

Symptomtext

FLUZONE HIGH-DOSE QUADRIVALENT administered to a 3 year old with no reported AE; FLUZONE HIGH-DOSE QUADRIVALENT administered to a 3 year old with no reported AE; Initial information was received on 19-Oct-2021 regarding an unsolicited valid non-serious case from a nurse. This case involves a three-year-old female patient who was administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (overdose, product administered to patient of inappropriate age). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 19-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (0.7mL, lot UJ751AA, expiry date 30-Jun-2022) via an unknown route at an unknown administration site for prophylactic vaccination. It was a case of actual medication error due to overdose and Inappropriate age at vaccine administration (latency: same day). At time of reporting, the outcome was unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 00819055:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Adverse reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1824750

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ751AA

gering
Staat
NY
Alter
0,8
Geschlecht
F
Eingang
28.10.2021
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

FLUZONE HIGH-DOSE QUADRIVALENT was administered to a 9 month old with no reported adverse event; FLUZONE HIGH-DOSE QUADRIVALENT was administered to a 9 month old with no reported adverse event; Initial information received on 19-Oct-2021 regarding an unsolicited valid non-serious case received from an other health professional in the . This case involves a 9-month-old and a 3-year-old female patient who administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] to a 9-month-old and a 3 year old [Product administered to patient of inappropriate age]. The patient medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS B VACCINE (HEPATITIS B [HEPATITIS B VACCINE]) for Prophylactic vaccination. On 19-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [Suspension for injection, lot UJ751AA and expiry date: 30-Jun-2022] via an intramuscular route in the left thigh for prophylactic vaccination. The patient visit on 19-oct-2021. It was a case of actual medication error due to product administered to patient of inappropriate age and overdose [Latency: on the same day]. It was reported "MD (Doctor of Medicine) and reviewed standard on children under 18 years. MD had question on what if the children experienced an adverse reaction do the parents contact Sanofi or contact them as the provider". Details of laboratory data not reported. It was not reported if the patient received any corrective treatment for the events. At time of reporting, the outcome was unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HEPATITIS B [HEPATITIS B VACCINE]
Allergien
-
Vorherige Impfungen
-